1,005
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Diagnostic value of BinaxNOW antigen card for Severe Acute Respiratory Syndrome Coronavirus 2

, , , , , , , , & show all
Article: 2180221 | Received 17 Apr 2022, Accepted 26 Jul 2022, Published online: 25 Jul 2023

Figures & data

Figure 1. Quality evaluation of the included studies.

Figure 1. Quality evaluation of the included studies.

Figure 2. Forest plots for the combined sensitivity(a), specificity(b), positive LR(c), negative LR(d) of BinaxNOW.

Figure 2. Forest plots for the combined sensitivity(a), specificity(b), positive LR(c), negative LR(d) of BinaxNOW.

Figure 3. Forest plots for the combined diagnostic OR of BinaxNOW(a) and summary receiver operating characteristic curves of COVID-19 infections detected by BinaxNOW(b).

Figure 3. Forest plots for the combined diagnostic OR of BinaxNOW(a) and summary receiver operating characteristic curves of COVID-19 infections detected by BinaxNOW(b).

Table 1. Subgroup analyses for the exploration of factors influencing heterogeneity in the BinaxNOW assay.

Table 2. Weighted meta-regression to assess the effects of various factors on the diagnostic accuracy of the BinaxNOW assay.

Figure 4. Deeks’ funnel plot asymmetry test to assess publication bias in estimates of diagnostic OR for BinaxNOW detection of COVID-19 infections.

Figure 4. Deeks’ funnel plot asymmetry test to assess publication bias in estimates of diagnostic OR for BinaxNOW detection of COVID-19 infections.
Supplemental material

Supplemental Material

Download Zip (844.7 KB)

Data availability statement

All data generated or analyzed during this study are included in this published article.